Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COMy Virtual 2020 | MRD in myeloma

Keith Stewart, MB, ChB, Mayo Clinic, Rochester, MN, talks on the assessment of measurable residual disease (MRD) in multiple myeloma. Dr Stewart addresses the benefits and challenges in MRD testing. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).